|RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas|
ZS Bao, HM Chen, MY Yang, CB Zhang, K Yu, WL Ye, BQ Hu, W Yan, ...
Genome research 24 (11), 1765-1773, 2014
|CGCG clinical practice guidelines for the management of adult diffuse gliomas|
T Jiang, Y Mao, W Ma, Q Mao, Y You, X Yang, C Jiang, C Kang, X Li, ...
Cancer letters 375 (2), 263-273, 2016
|HOTAIR is a therapeutic target in glioblastoma|
X Zhou, Y Ren, J Zhang, C Zhang, K Zhang, L Han, L Kong, J Wei, L Chen, ...
Oncotarget 6 (10), 8353, 2015
|Phosphoglycerate kinase 1 phosphorylates Beclin1 to induce autophagy|
X Qian, X Li, Q Cai, C Zhang, Q Yu, Y Jiang, JH Lee, D Hawke, Y Wang, ...
Molecular cell 65 (5), 917-931. e6, 2017
|Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma|
Z Wang, C Zhang, X Liu, Z Wang, L Sun, G Li, J Liang, H Hu, Y Liu, ...
Oncoimmunology 5 (11), e1196310, 2016
|Bioinformatic profiling identifies an immune-related risk signature for glioblastoma|
W Cheng, X Ren, C Zhang, J Cai, Y Liu, S Han, A Wu
Neurology 86 (24), 2226-2234, 2016
|ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole …|
J Cai, P Yang, C Zhang, W Zhang, Y Liu, Z Bao, X Liu, W Du, H Wang, ...
Oncotarget 5 (9), 2551, 2014
|MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis|
W Yan, R Li, Y Liu, P Yang, Z Wang, C Zhang, Z Bao, W Zhang, Y You, ...
Oncotarget 5 (24), 12908, 2014
|Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China|
CB Zhang, ZS Bao, HJ Wang, W Yan, YW Liu, MY Li, W Zhang, L Chen, ...
Journal of cancer research and clinical oncology 140 (1), 45-51, 2014
|Prognostic value of a nine‐gene signature in glioma patients based on mRNA expression profiling|
ZS Bao, MY Li, JY Wang, CB Zhang, HJ Wang, W Yan, YW Liu, W Zhang, ...
CNS neuroscience & therapeutics 20 (2), 112-118, 2014
|Tumor purity as an underlying key factor in glioma|
C Zhang, W Cheng, X Ren, Z Wang, X Liu, G Li, S Han, T Jiang, A Wu
Clinical Cancer Research 23 (20), 6279-6291, 2017
|A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients|
W Cheng, X Ren, J Cai, C Zhang, M Li, K Wang, Y Liu, S Han, A Wu
Oncotarget 6 (30), 29285, 2015
|Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance|
J Cai, W Zhang, P Yang, Y Wang, M Li, C Zhang, Z Wang, H Hu, Y Liu, ...
PloS one 10 (5), e0126022, 2015
|Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors|
J Cai, J Chen, W Zhang, P Yang, C Zhang, M Li, K Yao, H Wang, Q Li, ...
Oncotarget 6 (20), 18105, 2015
|Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas|
J Cai, P Zhu, C Zhang, Q Li, Z Wang, G Li, G Wang, P Yang, J Li, B Han, ...
Oncotarget 7 (13), 16384, 2016
|BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas|
Z Bao, C Zhang, W Yan, Y Liu, M Li, W Zhang, T Jiang
Journal of translational medicine 11 (1), 100, 2013
|Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis|
JH Lee, R Liu, J Li, C Zhang, Y Wang, Q Cai, X Qian, Y Xia, Y Zheng, ...
Nature communications 8 (1), 949, 2017
|Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution|
R Li, H Li, W Yan, P Yang, Z Bao, C Zhang, T Jiang, Y You
Oncotarget 6 (9), 7318, 2015
|Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas|
Y Liu, H Hu, K Wang, C Zhang, Y Wang, K Yao, P Yang, L Han, C Kang, ...
Oncotarget 5 (24), 12593, 2014
|miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma|
F Yang, X Liu, Y Liu, Y Liu, C Zhang, Z Wang, T Jiang, Y Wang
Cancer letters 396, 1-9, 2017